Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
19.80
-0.59 (-2.89%)
May 6, 2025, 4:00 PM EDT - Market closed

Enliven Therapeutics Analyst Ratings

Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$39.25
Upside
+98.23%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$37$39
Strong Buy Maintains $37$39 +96.97% Mar 21, 2025
BTIG
BTIG
Strong Buy
Initiates
$42
Strong Buy Initiates $42 +112.12% Dec 13, 2024
Baird
Baird
Buy
Maintains
$32$40
Buy Maintains $32$40 +102.02% Nov 15, 2024
Jones Trading
Jones Trading
Strong Buy
Initiates
$36
Strong Buy Initiates $36 +81.82% Oct 31, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$37
Strong Buy Reiterates $37 +86.87% Oct 1, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$37
Strong Buy Initiates $37 +86.87% Sep 9, 2024
Baird
Baird
Buy
Initiates
$32
Buy Initiates $32 +61.62% Jun 11, 2024
Mizuho
Mizuho
Strong Buy
Initiates
$34
Strong Buy Initiates $34 +71.72% Apr 9, 2024
Jefferies
Jefferies
Strong Buy
Initiates
$27
Strong Buy Initiates $27 +36.36% Mar 29, 2023
TD Cowen
TD Cowen
Buy
Initiates
n/a
Buy Initiates n/a n/a Mar 3, 2023